Your browser doesn't support javascript.
loading
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial.
Heinemann, Volker; von Weikersthal, Ludwig Fischer; Decker, Thomas; Kiani, Alexander; Vehling-Kaiser, Ursula; Al-Batran, Salah-Eddin; Heintges, Tobias; Lerchenmüller, Christian; Kahl, Christoph; Seipelt, Gernot; Kullmann, Frank; Stauch, Martina; Scheithauer, Werner; Hielscher, Jörg; Scholz, Michael; Müller, Sebastian; Link, Hartmut; Niederle, Norbert; Rost, Andreas; Höffkes, Heinz-Gert; Moehler, Markus; Lindig, Reinhard U; Modest, Dominik P; Rossius, Lisa; Kirchner, Thomas; Jung, Andreas; Stintzing, Sebastian.
Afiliação
  • Heinemann V; Department of Medical Oncology & Comprehensive Cancer Center, University Hospital Grosshadern, Munich, Germany. Electronic address: volker.heinemann@med.uni-muenchen.de.
  • von Weikersthal LF; Gesundheitszentrum St Marien, Amberg, Germany.
  • Decker T; Oncological Practice, Ravensburg, Germany.
  • Kiani A; Department of Medicine IV, Klinikum Bayreuth GmbH, Bayreuth, Germany.
  • Vehling-Kaiser U; Oncological Practice, Landshut, Germany.
  • Al-Batran SE; Department of Hematology and Oncology, Krankenhaus Nordwest, Frankfurt/Main, Germany.
  • Heintges T; Department of Medicine II, Städtisches Klinikum Neuss, Neuss, Germany.
  • Lerchenmüller C; Oncological Practice, Münster, Germany.
  • Kahl C; Haematology and Oncology, Städtisches Klinikum Magdeburg, Magdeburg, Germany.
  • Seipelt G; Oncological Practice, Bad Soden, Germany.
  • Kullmann F; Department of Medicine I, Klinikum Weiden, Germany.
  • Stauch M; Oncological Practice, Kronach, Germany.
  • Scheithauer W; Department of Internal Medicine I and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Hielscher J; Department of Surgery, Klinikum Chemnitz gGmbH, Chirurgische Onkologie, Chemnitz, Germany.
  • Scholz M; Department of Medicine, Klinikum Stuttgart Krankenhaus Bad Cannstatt, Stuttgart, Germany.
  • Müller S; Oncological Practice, Ansbach, Germany.
  • Link H; Department of Medicine I, Westpfalz-Klinikum GmbH, Kaiserslautern, Germany.
  • Niederle N; Department of Oncology, Haematology and Palliative Care, Klinikum Leverkusen gGmbH, Leverkusen, Germany.
  • Rost A; Medical Clinic V (Haematology and Oncology), Klinikum Darmstadt, Darmstadt, Germany.
  • Höffkes HG; Klinikum Fulda, Tumorklinik, Fulda, Germany.
  • Moehler M; Medical Department 1, Johannes-Gutenberg Universität Mainz, Mainz, Germany.
  • Lindig RU; Klinik für Innere Medizin II, Abteilung Hämatologie/Onkologie, Universitätsklinikum Jena, Jena, Germany.
  • Modest DP; Department of Medical Oncology & Comprehensive Cancer Center, University Hospital Grosshadern, Munich, Germany.
  • Rossius L; Department of Medical Oncology & Comprehensive Cancer Center, University Hospital Grosshadern, Munich, Germany; Institute of Pathology, University of Munich, Munich, Germany.
  • Kirchner T; Institute of Pathology, University of Munich, Munich, Germany.
  • Jung A; Institute of Pathology, University of Munich, Munich, Germany.
  • Stintzing S; Department of Medical Oncology & Comprehensive Cancer Center, University Hospital Grosshadern, Munich, Germany.
Lancet Oncol ; 15(10): 1065-75, 2014 Sep.
Article em En | MEDLINE | ID: mdl-25088940
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Camptotecina / Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica / Anticorpos Monoclonais Humanizados Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Camptotecina / Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica / Anticorpos Monoclonais Humanizados Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2014 Tipo de documento: Article